Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial This phase II trial enrolled 225 evaluable ...
Cheng Wang, CFA, is an equity analyst for Morningstar.* He covers China's education industry alongside industrials. Wang keeps a diverse coverage across education service providers, new energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results